
Krystal Biotech (KRYS) Earnings Dates & Reports
Krystal Biotech (KRYS) Most Recent Earnings
Report Date
Period EndingQ1 2026
Est. EPS$1.43
Actual EPS$1.83
EarningsBeat
Krystal Biotech (KRYS) Earnings
View the latest Krystal Biotech (KRYS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Krystal Biotech (KRYS)
Order type
Buy in
Order amount
Est. shares
0 shares
Krystal Biotech (KRYS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Krystal Biotech (KRYS) Latest Earnings
The value each KRYS share was expected to gain vs. the value each share gained.
Krystal Biotech (KRYS) reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of $1.83. This exceeded analysts' expectations of $1.43 by 27.97%, marking a Beat.
For comparison, Krystal Biotech reported EPS of $1.20 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $1.67.
Krystal Biotech (KRYS) Earnings History
Krystal Biotech (KRYS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Krystal Biotech’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Krystal Biotech (KRYS) Earnings FAQs
Krystal Biotech (KRYS) last reported earnings on May 4, 2026 for Q1 2026, posting an EPS of $1.83, which Beat the estimate of $1.43 by 27.97%.
For Q1 2026, Krystal Biotech (KRYS) reported an EPS of $1.83, exceeding analysts' estimate of $1.43 by 27.97%.
For Q1 2026, Krystal Biotech (KRYS) Beat expectations with an actual EPS of $1.83 vs. an estimated EPS of $1.43.
Following the last earnings report on May 4, 2026, Krystal Biotech (KRYS)'s stock price moved — from — to —.
The next Krystal Biotech (KRYS) earnings call is scheduled for Aug. 3, 2026, where executives will discuss financial results and outlook.